The FEN1 E359K germline mutation disrupts the FEN1–WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers
Linda H. Chung, Binghui Shen(Changchun University of Science and Technology), David Miruka Onyango(City Of Hope National Medical Center), Songbai Liu(Suzhou Vocational Health College), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Weihang Chai(Rosalind Franklin University of Medicine and Science), Karen L. Reckamp(Memorial Sloan Kettering Cancer Center), Wanzun Lin(Fudan University Shanghai Cancer Center), Judith Lopes(Centre National de la Recherche Scientifique), Li Zheng(Hebei Agricultural University), Zhigang Guo(Nanjing Normal University), Mian Zhou(Nanjing Drum Tower Hospital), Iok‐Hou Pang(City Of Hope National Medical Center), Alain Nicolas(Centre National de la Recherche Scientifique), Peiyao Jia(South China Normal University), Y-C Yuan(City Of Hope National Medical Center), H. Dai(City Of Hope National Medical Center), H Li(City Of Hope National Medical Center), Dan J. Raz(City Of Hope National Medical Center)
Cited by 29
Related Papers
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018
|Journal of the National Comprehensive Cancer Network|2018|471